Acetyl-Histone H3 (Lys14) Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context

Acetyl-Histone H3 (Lys14) Antibody is a polyclonal rabbit antibody targeting histone H3 acetylated at lysine 14 (H3K14ac), a post-translational modification associated with transcriptional activation . Histone H3 is a core component of nucleosomes, which compact DNA into chromatin. Acetylation at Lys14 reduces DNA-histone interactions, increasing chromatin accessibility for transcriptional machinery .

Western Blot (WB)

Used to detect H3K14ac levels in acid-extracted histones, providing insights into chromatin states during differentiation or disease .

Immunofluorescence (IF)

Visualizes H3K14ac localization in nuclei, correlating acetylation patterns with transcriptional activity .

ELISA

Quantifies H3K14ac levels using a sandwich assay:

  1. Capture: Monoclonal anti-histone H3 antibody immobilizes histones.

  2. Detection: Polyclonal anti-H3K14ac antibody binds specifically, followed by HRP-conjugated secondary antibody for colorimetric analysis .

Advantages over Immunoblotting:

  • Higher sensitivity (detects low-abundance modifications).

  • Faster results (<3 hours).

  • Quantitative data via spectrophotometry (450 nm) .

Validation and Quality Control

  • Specificity Testing: No cross-reactivity with non-acetylated H3 or other acetylated residues (e.g., H3K9ac, H3K27ac) .

  • Blocking Peptide Validation: A synthetic acetylated peptide (1–50 aa) confirms antibody specificity by abolishing signal in competition assays .

  • Formulation: Purified via affinity chromatography, ensuring >90% purity .

Transcriptional Regulation

H3K14ac is enriched at promoters of actively transcribed genes, serving as a marker for open chromatin. Studies link its levels to:

  • Embryonic development .

  • Cellular responses to DNA damage .

  • Cancer progression (e.g., aberrant acetylation in tumors) .

Chromatin Dynamics

H3K14ac facilitates recruitment of bromodomain-containing proteins (e.g., BRD4), which mediate transcriptional elongation .

Limitations and Ethical Considerations

  • Research Use Only: Not validated for diagnostic or therapeutic applications .

  • Sample Requirements: Requires acid-extracted histones or purified chromatin .

Product Specs

Buffer
Liquid in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide
Form
Liquid
Lead Time
Typically, we are able to ship orders within 1-3 business days of receipt. Delivery times may vary depending on the shipping method and destination. For specific delivery estimates, please contact your local distributor.
Uniprot No.

Q&A

What is Histone H3 acetylated at Lysine 14 and what is its biological significance?

Histone H3 acetylated at lysine 14 (H3K14ac) is a specific post-translational modification of histone H3 that plays a crucial role in transcriptional regulation. This modification has been correlated with the regulation of gene transcription, making it a significant marker in studying transcriptional activity. H3K14 acetylation corresponds to transcriptional activation and has been mapped to the initiation sites of actively transcribed genes .

The acetylation of H3K14 alters chromatin structure by neutralizing the positive charge of lysine, reducing the electrostatic interaction between histones and negatively charged DNA, thereby facilitating access of transcription machinery to DNA.

How does H3K14 acetylation interact with other histone modifications?

H3K14 acetylation functions within a complex network of histone modifications. Research indicates that H3K14ac can influence and be influenced by other modifications:

ModificationRelationship with H3K14acFunctional Outcome
H3K4me3Often co-occursEnhanced transcriptional activation
H3K9acFrequently present togetherAssociated with active promoters
H3K9me3Generally mutually exclusiveH3K14ac counteracts repressive effects
H3K36me2Complex interactionCan affect elongation phase of transcription

The CoREST complex (LHC) demethylase activity toward methyl-Lys4 in histone H3 is strongly inhibited by H3 Lys14 acetylation, demonstrating how this acetylation can protect activating marks from removal .

What are the primary research applications for H3K14ac antibodies?

Acetyl-Histone H3 (Lys14) antibodies are employed in numerous research applications:

ApplicationPurposeTypical Dilution
Western Blotting (WB)Detection of H3K14ac levels in protein extracts1:1000
Chromatin Immunoprecipitation (ChIP)Identification of genomic regions enriched with H3K14ac1:50
ChIP-sequencingGenome-wide mapping of H3K14ac distributionVariable
Immunofluorescence (IF)Visualization of cellular distribution1:400-1:3200
ELISAQuantitative measurement of H3K14ac levelsPer kit protocol
Immunohistochemistry (IHC)Detection in tissue sections1:800-1:3200

For optimal ChIP results, researchers typically use 10 μl of antibody and 10 μg of chromatin (approximately 4 x 10^6 cells) per immunoprecipitation .

How can H3K14ac levels be quantitatively measured in experimental samples?

Histone H3 acetyl Lys14 ELISA provides a sensitive, quantitative method for measuring H3K14ac levels:

  • Sandwich ELISA methodology:

    • A monoclonal histone H3 antibody captures histone H3 from purified core histones or acid-extracted histones

    • A polyclonal antibody specific for H3K14ac is used for detection

    • A secondary antibody conjugated to horseradish peroxidase (HRP) provides colorimetric readout

  • Sensitivity and range:

    • Detection range: 0.06 to 2 micrograms of core histone preparations

    • Detection range for acid extracts: 0.03 to 1 micrograms

  • Advantages over immunoblotting:

    • Increased sensitivity

    • Results in less than three hours

    • Specific antibody detection ensures low background

    • Quantitative analysis via spectrophotometry at 450 nm

    • 96-stripwell format for high or low throughput screening

For standardization, recombinant Histone H3 acetyl Lys14 protein (99% pure) can be used to build reference standard curves .

How is the specificity of Acetyl-Histone H3 (Lys14) antibodies validated?

Validating antibody specificity is critical for accurate experimental results. Multiple approaches are used:

  • Cross-reactivity testing with peptide arrays:

    • Antibodies are tested against peptides containing various histone modifications

    • For example, RM130 antibody specifically reacts to H3K14ac with no cross-reactivity to other acetylated lysines (K4ac, K9ac, K18ac, K23ac, K27ac, K36ac, or K79ac)

  • Dot blot analysis:

    • Peptide samples (typically 0.1 μg) are spotted onto positively charged nylon membrane

    • Membranes are probed with antibody at different dilutions

    • Comparison between modified and unmodified peptides demonstrates specificity

  • Western blot validation:

    • Using acid extracts from cells treated with and without histone deacetylase inhibitors (e.g., sodium butyrate, Trichostatin A)

    • Treatment increases acetylation levels, providing a positive control

  • ChIP-PCR of known targets:

    • Verification by ChIP followed by PCR of genomic regions known to be enriched for H3K14ac

How do neighboring histone modifications affect H3K14ac antibody binding?

  • Epitope occlusion phenomena:

    • Some antibodies may show reduced binding if nearby residues are modified

    • For example, phosphorylation of serine 10 (S10ph) might affect binding of some H3K14ac antibodies

  • Validating antibody in context-specific manner:

    • When studying highly modified chromatin regions, antibody binding efficiency should be verified

    • Synthetic peptides with combinations of modifications can be used to test for interference

  • Quantitative considerations:

    • Signal strength may vary depending on the modification status of surrounding residues

    • Control experiments with defined modification patterns are recommended for quantitative studies

How does H3K14 acetylation interact with chromatin-modifying enzyme complexes?

The interaction between H3K14ac and chromatin-modifying enzyme complexes reveals sophisticated regulatory mechanisms:

  • CoREST complex interaction:

    • The core CoREST complex (LHC) contains histone deacetylase HDAC1 and histone demethylase LSD1

    • H3K14 acetylation strongly inhibits LHC demethylase activity toward methyl-Lys4 in histone H3

    • This appears to be an intrinsic property of the LSD1 subunit

  • Selective deacetylation patterns:

    • The deacetylase selectivity of LHC shows marked preference for H3 acetyl-Lys9 versus acetyl-Lys14 in nucleosome substrates

    • This selectivity is lost with isolated acetyl-Lys H3 protein, suggesting nucleosome context is important

    • The diminished activity toward Lys-14 deacetylation in nucleosomes is not merely due to steric accessibility

These findings indicate H3K14ac functions as a protective mark that confers resistance to certain enzyme complexes, potentially stabilizing active transcriptional states.

What genome-wide distribution patterns of H3K14ac are observed in various cell types and conditions?

ChIP-seq studies have revealed distinctive distribution patterns of H3K14ac:

  • Promoter enrichment:

    • H3K14ac is predominantly found at promoters of actively transcribed genes

    • Often co-occurs with H3K4me3 and RNA Polymerase II occupancy

  • Cell-type specific patterns:

    • Distribution varies between cell types, reflecting differential gene expression

    • Changes in H3K14ac patterns correlate with developmental transitions

  • Response to stimuli:

    • Rapid changes in H3K14ac distribution occur in response to stimuli

    • For example, stress conditions can induce global changes in acetylation patterns

  • Species-specific considerations:

    • In Plasmodium falciparum, H3K14ac shows unique mechanisms of transcriptional regulation

    • In yeast, complex patterns of epigenomic variation exist between natural strains at single-nucleosome resolution

Understanding these genome-wide patterns helps elucidate the role of H3K14ac in transcriptional regulation across different biological contexts.

What are common technical challenges when working with H3K14ac antibodies and how can they be addressed?

Researchers frequently encounter specific challenges when using H3K14ac antibodies:

ChallengePotential Solution
High background in ChIPPre-clear chromatin, use more stringent washing, optimize antibody amount
Weak signal in Western blotsConfirm extraction method preserves acetylation, increase protein loading, use HDAC inhibitors
Inconsistent ChIP-seq resultsEnsure antibody lot consistency, include spike-in controls, normalize data appropriately
Cross-reactivity concernsValidate with peptide competition assays, compare results with multiple antibody clones
Signal variability between experimentsUse recombinant H3K14ac standards, include internal controls, standardize protocols

For ChIP applications specifically, researchers should:

  • Use the recommended amount of antibody (typically 10 μl) and chromatin (10 μg)

  • Include appropriate positive and negative controls

  • Consider using validated ChIP kits that have been tested with H3K14ac antibodies

How can researchers effectively integrate H3K14ac data with other epigenetic marks for comprehensive chromatin state analysis?

Advanced research often requires integration of multiple epigenetic datasets:

  • Multivariate analysis approaches:

    • Chromatin state modeling using hidden Markov models

    • Genome segmentation based on combinations of marks

    • Correlation analysis between H3K14ac and other modifications

  • Sequential ChIP methodology:

    • First immunoprecipitate with H3K14ac antibody

    • Re-ChIP the material with antibody against another modification

    • Identifies genomic regions containing both modifications simultaneously

  • Mass spectrometry integration:

    • Complementing ChIP data with mass spectrometry analysis

    • Provides quantitative information about co-occurring modifications

    • Can reveal combinatorial patterns not detectable by individual ChIP experiments

  • Functional validation experiments:

    • CRISPR-based recruitment of histone acetyltransferases

    • Site-directed mutagenesis of K14 residue

    • Inhibitor studies targeting specific enzymes that modify H3K14

By combining these approaches, researchers can develop more complete models of how H3K14ac functions within the broader epigenetic landscape to regulate gene expression and chromatin structure.

Histone H3 (Lys14) Acetylation: Methodological Guide for Researchers

What are the optimal extraction methods to preserve histone acetylation for H3K14ac analysis?

For accurate analysis of histone acetylation at H3K14, proper extraction and sample preparation is crucial:

  • Acid extraction protocol:

    • Harvest cells and wash with ice-cold PBS

    • Resuspend cell pellet in Triton Extraction Buffer (PBS containing 0.5% Triton X-100, 2mM PMSF, 0.02% NaN₃)

    • Lyse cells on ice for 10 minutes with gentle stirring

    • Centrifuge at 6,500 × g for 10 minutes at 4°C

    • Resuspend pellet in 0.2N HCl

    • Incubate overnight at 4°C with rotation

    • Centrifuge at 6,500 × g for 10 minutes at 4°C

    • Transfer supernatant to a new tube

    • Neutralize with 1/10 volume of 2M NaOH

  • Critical considerations:

    • Include HDAC inhibitors (sodium butyrate at 5-10 mM or Trichostatin A at 0.3-0.4 μM) in all buffers

    • Use protease inhibitor cocktails to prevent degradation

    • Maintain cold temperatures throughout the procedure

    • Process samples quickly to minimize loss of modifications

These extraction methods are compatible with various downstream applications including ELISA, which can detect H3K14ac within a range of 0.03 to 1 micrograms of acid extract .

How should experimental controls be designed for H3K14ac studies?

Proper experimental controls are essential for reliable H3K14ac research:

Control TypePurposeImplementation
Positive controlVerify antibody functionalityUse cells treated with HDAC inhibitors (sodium butyrate, Trichostatin A)
Negative controlEstablish background levelsUse IgG from same species as H3K14ac antibody
Input controlNormalize for DNA abundanceProcess aliquot of starting material without immunoprecipitation
Peptide competitionConfirm antibody specificityPre-incubate antibody with H3K14ac peptide before experiment
Recombinant standardsEnable quantitationInclude recombinant H3K14ac protein standard curve

For ChIP experiments specifically:

  • Include genomic regions known to be enriched for H3K14ac (positive loci)

  • Include genomic regions known to lack H3K14ac (negative loci)

  • Consider using spike-in chromatin from different species for normalization

Recombinant Histone H3 acetyl Lys14 protein (99% pure) is available with some ELISA kits and can be used to build reference standard curves for accurate quantitation .

How can H3K14ac ChIP-seq data be effectively analyzed and integrated with other genomic datasets?

Analysis of H3K14ac ChIP-seq data requires specific computational approaches:

  • Primary analysis pipeline:

    • Quality control: FastQC to assess sequence quality

    • Alignment: Map reads to reference genome (Bowtie2, BWA)

    • Peak calling: Identify enriched regions (MACS2, SICER)

    • Visualization: Generate coverage tracks (deepTools, IGV)

  • Integration strategies:

    • Correlation with gene expression data (RNA-seq)

    • Overlap with other histone modifications (bedtools, ChromHMM)

    • Motif enrichment analysis to identify associated transcription factors

    • Pathway analysis of genes associated with H3K14ac peaks

  • Multi-omics integration example:

    • In Plasmodium falciparum studies, H3K14ac data was integrated with other epigenetic marks to create comprehensive epigenome maps

    • This revealed unique mechanisms of transcriptional regulation

    • H3K36me2 was identified as a global mark of gene suppression in relation to acetylation patterns

  • Advanced normalization approaches:

    • Spike-in normalization for comparing conditions

    • Quantile normalization for batch correction

    • Signal extraction scaling (SES) for antibody efficiency differences

These approaches enable researchers to extract maximum biological insight from H3K14ac ChIP-seq datasets and place findings in broader genomic context.

What emerging technologies are enhancing our ability to study H3K14ac dynamics?

Recent technological advances are providing new insights into H3K14ac:

  • CUT&RUN and CUT&Tag alternatives to ChIP:

    • Improved signal-to-noise ratio compared to conventional ChIP

    • Requires fewer cells (down to 1,000)

    • More sensitive detection of H3K14ac in limited samples

    • Reduced background compared to ChIP-seq

  • Single-cell approaches:

    • scCUT&Tag for single-cell profiling of H3K14ac

    • Reveals cell-to-cell heterogeneity in acetylation patterns

    • Can be integrated with scRNA-seq for multi-omic analysis

  • Live-cell imaging of H3K14ac:

    • Antibody-based fluorescent probes

    • Engineered reader domains that specifically recognize H3K14ac

    • Enables real-time monitoring of acetylation dynamics

  • Mass spectrometry advancements:

    • Quantitative analysis of combinatorial histone modifications

    • Middle-down MS approaches that preserve longer histone tail fragments

    • Can identify co-occurrence of H3K14ac with other modifications on the same histone molecule

  • CRISPR-based epigenome editing:

    • Targeted modification of H3K14ac at specific loci

    • dCas9 fused to histone acetyltransferases or deacetylases

    • Allows causal testing of H3K14ac function at specific genomic locations

These technologies are expanding our understanding of H3K14ac beyond static snapshots to dynamic, site-specific, and single-cell resolution views of its function.

How does H3K14 acetylation respond to environmental stress and signaling pathways?

H3K14 acetylation shows dynamic responses to various stimuli:

  • Stress response patterns:

    • Osmotic stress induces specific changes in H3K14ac distribution

    • In Arachis hygogaea (peanut), an osmotic stress and ABA-induced histone deacetylase affecting H3K14ac was isolated and characterized

    • This suggests a regulatory mechanism for stress adaptation involving H3K14ac

  • Signaling pathway integration:

    • Insulin signaling affects H3K14ac distribution

    • Studies have shown epigenetic activation of Egr-1 and JunB genes at the nuclear periphery involves H3K14ac

    • This process is mediated by A-type lamin-associated pY19-Caveolin-2 in the inner nuclear membrane

  • Temporal dynamics:

    • H3K14ac changes can occur rapidly (within minutes) after stimulus

    • Different genes show distinct temporal patterns of acetylation

    • Some changes are transient while others are sustained

  • Therapeutic implications:

    • HDAC inhibitors affect H3K14ac levels with gene-specific effects

    • mRNA levels of related Abcb genes change in opposite directions upon histone deacetylase inhibition in drug-resistant cells

    • This has implications for understanding drug resistance mechanisms

These findings highlight H3K14ac as a dynamic epigenetic mark that integrates various cellular signals and environmental conditions.

What is the role of H3K14ac in disease processes and potential therapeutic interventions?

H3K14 acetylation has been implicated in various disease contexts:

  • Cancer epigenetics:

    • Altered H3K14ac patterns observed in multiple cancer types

    • Can serve as a biomarker for disease progression

    • Target of epigenetic therapies including HDAC inhibitors

  • Neurodevelopmental conditions:

    • Epigenetics of Notch1 regulation involving H3K14ac has been studied in pulmonary microvascular rarefaction following extrauterine growth restriction

    • This has implications for understanding developmental disorders

  • Infectious disease:

    • In Plasmodium falciparum, H3K14ac is part of a complex epigenetic landscape

    • Understanding parasite-specific epigenetic regulation could lead to new therapeutic approaches

    • Small-molecule disruptors of heterochromatin-mediated transcriptional gene silencing affect H3K14ac patterns

  • Therapeutic monitoring applications:

    • Changes in H3K14ac can be monitored to assess efficacy of epigenetic therapies

    • ELISAs provide quantitative tools for measuring these changes in clinical samples

    • Specific antibodies enable precise targeting of this modification in diagnostic applications

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.